glucagon has been researched along with imeglimin in 2 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (imeglimin) | Trials (imeglimin) | Recent Studies (post-2010) (imeglimin) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 54 | 16 | 52 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolze, S; Fouqueray, P; Mari, A; Pacini, G; Roden, M | 1 |
| Aiba, S; Baba, Y; Hirayama, K; Iga, R; Inaba, Y; Ishibashi, R; Ito, C; Kanayama, T; Kasahara, K; Koshizaka, M; Kuroda, Y; Maezawa, Y; Ohtani, R; Okano, K; Watanabe, S; Yokote, K | 1 |
1 trial(s) available for glucagon and imeglimin
| Article | Year |
|---|---|
Imeglimin increases glucose-dependent insulin secretion and improves β-cell function in patients with type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucagon; Glucose Clamp Technique; Hepatobiliary Elimination; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Triazines | 2015 |
1 other study(ies) available for glucagon and imeglimin
| Article | Year |
|---|---|
Imeglimin-mediated glycemic control in maternally inherited deafness and diabetes.
Topics: Blood Glucose; Deafness; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glucagon; Glycemic Control; Humans; Hypoglycemic Agents; Maternal Inheritance; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors | 2023 |